Publications by authors named "Davide Termini"

Claim this Profile
R
Romosozumab for Glucocorticosteroid-Induced Osteoporosis in Patients With Autoimmune Blistering Diseases: Primum Non Nocere.
Carlo Alberto Maronese, Gianluca Avallone, Davide Termini, Angelo Valerio Marzano

Int J Dermatol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful treatment of Hailey-Hailey disease with oral roflumilast.
Giovanni Genovese, Carlo Alberto Maronese, Davide Termini, Luisa Sarno, Stefano Buffon

Clin Exp Dermatol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual Biologic Therapy With Dupilumab and Risankizumab for Coexistent Prurigo Nodularis and Psoriasis.
Davide Termini, Gianluca Tavoletti, Gianluca Avallone, Alessandra Chiei Gallo, Francesca L Boggio

Int J Dermatol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pan-JAK Inhibition Across Chronic Hand Eczema and Other Cutaneous Diseases: An Updated Review on Topical Delgocitinib.
Davide Termini, Gianluca Avallone, Gianluca Tavoletti, Jessica Beaziz, Chiara Moltrasio

Drugs· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phenotypic Switch From Atopic Dermatitis to Psoriasis During Dupilumab Therapy: A Real-Life Experience From a Tertiary Referral Center.
Alessandra Chiei Gallo, Gianluca Tavoletti, Davide Termini, Gianluca Avallone, Francesca Barei

Int J Dermatol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fatal Toxic Epidermal Necrolysis-Like Lupus Erythematosus in a Patient With Metastatic Histiocytic Sarcoma.
Carlo Alberto Maronese, Federica Derlino, Davide Termini, Stefano Buffon, Luisa Sarno

Int J Dermatol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of Tralokinumab for Moderate-to-Severe Atopic Dermatitis Involving the Head-and-Neck Area: A Multicenter Retrospective Cohort Study.
Gianluca Avallone, Luca Valtellini, Gianluca Tavoletti, Luca Mastorino, Martina Maurelli, Davide Termini

Dermatitis· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful treatment of prurigo nodularis with upadacitinib.
Gianluca Avallone, Andrea Bombelli, Davide Termini, Alessandra Chiei-Gallo, Paolo Calzari

Clin Exp Dermatol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness and safety of combined dupilumab and risankizumab in concomitant atopic dermatitis and psoriasis.
Davide Termini, Gianluca Tavoletti, Alessandra Chiei-Gallo, Gianluca Avallone, Francesca L Boggio

Int J Dermatol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of Dupilumab and Omalizumab in Bullous Pemphigoid: A Nationwide Retrospective Cohort Study.
Gianluca Avallone, Carlo Alberto Maronese, Martina Zussino, Simona Muratori, Silvia Mariel Ferrucci, Davide Termini

J Dermatol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tralokinumab-induced psoriasis relapse in a patient with atopic dermatitis.
Alessandra Chiei Gallo, Gianluca Tavoletti, Davide Termini, Angelo V Marzano, Silvia M Ferrucci

Int J Dermatol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis